AmirAli Talasaz, Chairman, President and COO at Guardant Health, Inc. (GH), sold 361,827 shares at $152.17 ($56.4M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $56.4M GH by Chairman, President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.16 | 798 | $121K | 0.2% |
| 2 | $152.16 | 798 | $121K | 0.2% |
| 3 | $152.17 | 5,333 | $812K | 1.4% |
| 4 | $152.17 | 5,333 | $812K | 1.4% |
| 5 | $153.19 | 1,503 | $230K | 0.4% |
| 6 | $153.19 | 10,468 |
| $1.6M |
| 2.8% |
| 7 | $153.19 | 10,468 | $1.6M | 2.8% |
| 8 | $153.19 | 1,503 | $230K | 0.4% |
| 9 | $153.98 | 28,374 | $4.4M | 7.7% |
| 10 | $153.98 | 4,222 | $650K | 1.2% |
| 11 | $153.98 | 4,222 | $650K | 1.2% |
| 12 | $153.98 | 28,374 | $4.4M | 7.7% |
| 13 | $155.10 | 7,596 | $1.2M | 2.1% |
| 14 | $155.10 | 7,596 | $1.2M | 2.1% |
| 15 | $155.10 | 50,011 | $7.8M | 13.8% |
| 16 | $155.10 | 50,011 | $7.8M | 13.8% |
| 17 | $155.87 | 122 | $19K | 0.0% |
| 18 | $155.92 | 1,066 | $166K | 0.3% |
| 19 | $155.92 | 1,066 | $166K | 0.3% |
| 20 | $157.02 | 28 | $4K | 0.0% |
| 21 | $157.02 | 492 | $77K | 0.1% |
| 22 | $157.02 | 492 | $77K | 0.1% |
| 23 | $155.87 | 803 | $125K | 0.2% |
| 24 | $155.88 | 4,629 | $722K | 1.3% |
| 25 | $156.79 | 9,619 | $1.5M | 2.7% |
| 26 | $156.79 | 1,355 | $212K | 0.4% |
| 27 | $157.63 | 57,542 | $9.1M | 16.1% |
| 28 | $158.91 | 43,478 | $6.9M | 12.2% |
| 29 | $158.92 | 6,772 | $1.1M | 1.9% |
| 30 | $159.53 | 2,128 | $339K | 0.6% |
| 31 | $159.54 | 15,625 | $2.5M | 4.4% |
| Total | $155.90 avg | 361,827 | $56.4M | 100% |
| Filing → |
| GH | SELL | 2026-05-22 | $23.1M | — | Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |